This story originally provided by The Charleston Gazette
August 18, 2004
Special session on drug prices may be
off
Gov. Bob Wise appeared Tuesday to back off plans to call a
legislative special session to deal with high prescription drug
costs this year.
Asked whether he will call a special session before the end of
the year to act on measures to control rising prescription drug
costs, Wise said it’s a “possibility.”
“I don’t know if there will be a special session,” he
added.
That’s a dramatic change from Wise’s comments when the
Legislature passed the landmark Pharmaceutical Availability and
Affordability Act of 2004 in March.
The law created the state Pharmaceutical Cost Management Council,
which is to recommend ways to save money on prescription drugs by
Sept. 15.
In March, Wise said he planned to call lawmakers to Charleston to
act on the council’s recommendations before the November
elections.
“We will go the Legislature as soon as possible,” the
governor said at the time. “We’re going to be as aggressive as
we can to implement this.”
On Tuesday, Wise ruled out taking up the recommendations of the
11-member pharmaceutical panel next month, when he is expected to
call a special session for flood relief funding. That session is
likely to follow the monthly legislative interim meetings, scheduled
for Sept. 19-21.
“You need to give the Legislature time to digest it,” Wise
said of the council’s recommendations for lowering prescription
drug costs. “My sense is, it will be pretty complex.”
The council is expected to vote on the first of its cost-savings
proposals on Aug. 24.
Wise said members of his administration have been negotiating
with drug manufacturers separately to come up with cost-savings
agreements for the state.
“The Pharmaceutical Council is running on one track, and I’ve
been working with my administration as well in other areas,” Wise
said.
Wise said the negotiations with drug company representatives have
been productive.
Delegate Don Perdue, D-Wayne, a pharmacist and one of the
architects of the legislation, said Tuesday he was disappointed but
not entirely surprised by Wise’s comments.
“Delay is death to this legislation,” Perdue said. “If
it’s delayed very much, the drug industry will flex its
muscles.”
If Wise declines to call a special session, the council’s
recommendations would be on the legislative agenda for the 2005
regular session, beginning in February.
Under the act, the full Legislature can either approve or reject
the council’s recommendations. If it rejects the council’s
proposals, the Legislature would then have to approve or reject a
statewide drug-pricing schedule based on the deeply discounted
Federal Supply Schedule.
Perdue said he is convinced that if the Legislature puts off
acting on the council’s recommendations until February, drug
industry lobbyists will be able to derail the council’s work.
“The drug industry, especially Mr. [Phil] Reale, their local
lobbyist here, has done a real good job of muddying up the waters
enough so that people are afraid to dive in,” Perdue said. Reale
was chief of staff for former Gov. Gaston Caperton.
To contact staff writer Phil Kabler, use e-mail or call 348-1220.
|